KATELYN FREEMAN: Open Payments
NPI 1962935080 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,662 in 38 payments from 17 companies in 2025. Trend: 2023 $2,047 · 2024 $4,100 · 2025 $1,662
Food & beverage: $1,662
| Company | Payments | Amount |
|---|---|---|
| CORDIS US CORP. | 3 | $475 |
| Medtronic, Inc. | 3 | $253 |
| Biosense Webster, Inc. | 2 | $212 |
| Merck Sharp & Dohme LLC | 6 | $157 |
| Boston Scientific Corporation | 1 | $146 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $87 |
| E.R. Squibb & Sons, L.L.C. | 3 | $52 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
Products named: MYNX CONTROL VENOUS, COBALT DR MRI SURESCAN, CARTO 3, ACCOLADE SR, VERQUVO, JARDIANCE, CAMZYOS, LEQVIO.
Industry payments across AZ — which companies pay providers there.
